Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000143

Chairperson & CEO sold 9,500 shares at an average $501.39 ($4,763,172)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-16 Sale : show line 2 in the form 10b5-1 −2,080 $498.45 $1,036,777 331,863 I
2026-09-16 Sale : show line 3 in the form 10b5-1 −1,220 $499.15 $608,966 330,643 I
2026-09-16 Sale : show line 4 in the form 10b5-1 −492 $500.19 $246,096 330,151 I
2026-09-16 Sale : show line 5 in the form 10b5-1 −708 $501.52 $355,077 329,443 I
2026-09-16 Sale : show line 6 in the form 10b5-1 −2,160 $502.44 $1,085,272 327,283 I
2026-09-16 Sale : show line 7 in the form 10b5-1 −1,538 $503.53 $774,429 325,745 I
2026-09-16 Sale : show line 8 in the form 10b5-1 −1,182 $504.17 $595,932 324,563 I
2026-09-16 Sale : show line 9 in the form 10b5-1 −120 $505.20 $60,624 324,443 I
Open-market sales · 9,500 sh · avg $501.39 · $4,763,172

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-16 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −9,500 423,410 I
Loading xslF345X06/primarydocument.xml…